PhoenixBio Co., Ltd. (TYO:6190)
Japan · Delayed Price · Currency is JPY 444.00
-2.00 (-0.45%)
Apr 17, 2026, 3:30 PM JST
PhoenixBio Market Cap
PhoenixBio has a market cap or net worth of 1.81 billion as of April 17, 2026. Its market cap has increased by 19.94% in one year.
Market Cap
1.81B
Enterprise Value
1.09B
Revenue
1.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
444.00
Market Cap Chart
Since March 18, 2016, PhoenixBio's market cap has decreased from 8.06B to 1.81B, a decrease of -77.57%. That is a compound annual growth rate of -13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.81B | -8.26% |
| Dec 30, 2025 | 1.97B | 47.38% |
| Dec 30, 2024 | 1.34B | -23.59% |
| Dec 29, 2023 | 1.75B | -25.42% |
| Dec 30, 2022 | 2.35B | 39.61% |
| Dec 30, 2021 | 1.68B | -13.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kohjin Bio | 6.96B |
| Soiken Holdings | 6.57B |
| Noile-Immune Biotech | 6.50B |
| TMS Co., Ltd. | 6.46B |
| Linical | 5.74B |
| D. Western Therapeutics Institute | 5.11B |
| Ribomic | 4.67B |
| Transgenic Group | 4.40B |